Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
3.45M
-
Number of holders
-
28
-
Total 13F shares, excl. options
-
21.7M
-
Shares change
-
-8.35M
-
Total reported value, excl. options
-
$3.6M
-
Value change
-
-$1.47M
-
Number of buys
-
12
-
Number of sells
-
-10
-
Price
-
$0.17
Significant Holders of IN8BIO, INC. - Common Stock, $0.0001 par value per share (INAB) as of Q1 2025
31 filings reported holding INAB - IN8BIO, INC. - Common Stock, $0.0001 par value per share as of Q1 2025.
IN8BIO, INC. - Common Stock, $0.0001 par value per share (INAB) has 28 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 21.7M shares
.
Largest 10 shareholders include BIOS Capital Management, LP (8.6M shares), FRANKLIN RESOURCES INC (5.7M shares), Alyeska Investment Group, L.P. (2.08M shares), VANGUARD GROUP INC (1.8M shares), AIGH Capital Management LLC (1.45M shares), Sigma Planning Corp (701K shares), GEODE CAPITAL MANAGEMENT, LLC (569K shares), Stonegate Investment Group, LLC (180K shares), NORTHERN TRUST CORP (93.4K shares), and STATE STREET CORP (88.7K shares).
This table shows the top 28 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.